Athenex announces positive results of special stockholder meeting

Buffalo, n.y., nov. 22, 2022 (globe newswire) -- athenex, inc., (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced the results of its special meeting of stockholders (the “special meeting”), held as a virtual meeting on november 22, 2022.

ATNX Ratings Summary

ATNX Quant Ranking